Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

Obesity Surgery

Volumn 25, Issue 1, 2015, Pages 97-108

  Sanchis, Pilar ^a   Frances, Carla ^a   Nicolau, Joana ^a   Rivera, Rosmeri ^a   Fortuny, Regina ^a   Julian, Xavier ^a   Pascual, Salvador ^a   Gomez, Luis A ^a   Rodriguez, Irene ^a   Olivares, Josefina ^a   Ayala, Luisa ^a   Masmiquel, Luis ^a  

^a HOSPITAL SON LLÀTZER   (Spain)

Author keywords

Bariatric surgery; Cardiovascular risk profile; Hypercholesterolemia; Lifestyle intervention; Morbid obesity; Type II diabetes

Indexed keywords

ADULT; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SOUTHERN EUROPE; STATISTICS AND NUMERICAL DATA; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MEDITERRANEAN REGION; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 84939885541     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1321-z     Document Type: Article

References (50)

1. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–78.
2. Vest AR, Heneghan HM, Schauer PR, et al. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127(8):945–59. doi:10.1161/CIRCULATIONAHA.112.103275.
3. Jiang J, Ahn J, Huang WY, et al. Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med. 2013;57(1):60–4. doi:10.1016/j.ypmed.2013.04.014.
4. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration BMI Mediated Effects. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2013. doi:10.1016/S0140-6736(13)61836-X.
5. Must A, Spadano Van Gaal LF, Maggioni AP. Overweight, obesity, and outcomes: fat mass and beyond. Lancet. 2013. doi:10.1016/S0140-6736(13)62076-0.
6. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9. doi:10.1056/NEJMoa1000367.
7. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290(7):932–40.
8. Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev. 2011;12(5):e282–9. doi:10.1111/j.1467-789X.2010.00807.x.
9. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. doi:10.1056/NEJMoa035622.
10. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61. doi:10.1056/NEJMoa066603.
11. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. doi:10.1001/jama.2011.1914.
12. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. doi:10.1001/jama.299.3.316.
13. Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735–45. doi:10.1530/EJE-10-0514.
14. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36. doi:10.1007/s11695-012-0864-0.
15. Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90(1):15–22. doi:10.3945/ajcn.2009.27583.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81–90. doi:10.2337/dc14-S081.
17. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5. doi:10.2337/dc09-9036.
18. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.
19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.
20. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999 22(5):667-89.
21. Wood D, De Backer G, Faergeman O, et al. Task Force Report. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of the joint European Societies on coronary prevention. Eur Heart J. 1998;19(10):1434–503.
22. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 16;285(19):2486-97.
23. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110(2):227–39.
24. Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83(1):356–62.
25. Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.
26. Menotti A, Lanti M, Puddu PE, et al. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000;84(3):238–44.
27. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21(5):365–70.
28. Marrugat J, Solanas P, D’Agostino R, et al. Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp Cardiol. 2003;56(3):253–61.
29. Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary risk function to southern Europe Mediterranean areas. J Epidemiol Community Health. 2003;57(8):634–8.
30. Comín E, Solanas P, Cabezas C, et al. Estimating cardiovascular risk in Spain using different algorithms. Rev Esp Cardiol. 2007;60(7):693–702.
31. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care. 1979;2(2):120–6.
32. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.
33. Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108(10):1499–507. doi:10.1016/j.amjcard.2011.06.076.
34. Ortega E, Morínigo R, Flores L, et al. Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc. 2012;26(6):1744–50. doi:10.1007/s00464-011-2104-4.
35. Dixon JB, Dixon ME, O'Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg. 2001;11(2):200–7.
36. Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701. doi:10.1161/CIR.0b013e3182149099.
37. Martins C, Strømmen M, Stavne OA, et al. Bariatric surgery versus lifestyle interventions for morbid obesity–changes in body weight, risk factors and comorbidities at 1 year. Obes Surg. 2011;21(7):841–9. doi:10.1007/s11695-010-0131-1.
38. Jacobson TA. Lipoprotein (a), cardiovascular disease, and contemporary management. Mayo Clin Proc. 2013;88(11):1294–311. doi:10.1016/j.mayocp.2013.09.003.
39. Thompson GR, Seed M. Lipoprotein (a): the underestimated cardiovascular risk factor. Heart. 2013. doi:10.1136/heartjnl-2013-304902.
40. Dixon JB, Dixon ME, O'Brien PE. Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obes Relat Metab Disord. 2001;25(2):219–27.
41. Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–6. discussion 757-8.
42. Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. doi:10.1056/NEJMoa1212914.
43. Gerstein HC. Do lifestyle changes reduce serious outcomes in diabetes? N Engl J Med. 2013;369(2):189–90. doi:10.1056/NEJMe1306987.
44. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442–9. doi:10.2337/dc09-0749.
45. Edward H, Livingston MD. Inadequacy of BMI as an indicator for bariatric surgery. JAMA. 2012;307(1):88–9. doi:10.1001/jama.2011.1950.
46. Livingston EH. Pitfalls in using BMI as a selection criterion for bariatric surgery. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):347–51. doi:10.1097/MED.0b013e328357f0b8.
47. Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One. 2012;7(4):e33308. doi:10.1371/journal.pone.0033308.
48. Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36(2):286–94. doi:10.1038/ijo.2011.100.
49. Gómez-Ambrosi J, Silva C, Catalán V, et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care. 2012;35(2):383–8.
50. Benaiges D, Goday A, Ramon JM, et al. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis. 2011;7(5):575–80. doi:10.1016/j.soard.2011.03.002.